Amgen To Present At The Goldman Sachs 37th Annual Global Healthcare Conference
Get Alerts AMGN Hot Sheet
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.3%
Revenue Growth %: +22.5%
Join SI Premium – FREE
THOUSAND OAKS, Calif., June 3, 2016 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Goldman Sachs 37th Annual Global Healthcare Conference at 1:20 p.m. PT on Tuesday, June 7, 2016, in Rancho Palos Verdes, Calif. Sean E. Harper, M.D., executive vice president of Research and Development at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.
About AmgenAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand OaksKristen Davis, 805-447-3008 (media)Kristen Neese, 805-313-8267 (media)Arvind Sood, 805-447-1060 (investors)
Logo - http://photos.prnewswire.com/prnh/20081015/AMGENLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-goldman-sachs-37th-annual-global-healthcare-conference-300279526.html
SOURCE Amgen
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ITE HCMC 2024: Pioneering Sustainable Tourism for a Creating Future
- Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
- Summit Clinical Research Statement on Co-Founder and Chairman Dr. Stephen Harrison
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Goldman Sachs, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!